Delivery Order SPE2DB20D1050-SPE2DB24FH62P
Award Date 4/24/24
Potential Completion Date 4/25/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,839.36 for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 12, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE medicine. The award has a potential value of $4,842.48 and a completion date of February 16, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00, which serves as the primary contract vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of COPAXONE 40 MG/ML SYRINGE syringes. The contract, a Firm Fixed Price Delivery Order valued at $1,646.65, was awarded by the Defense Logistics Agency (DLA), a defense agency. The ultimate completion date is July 16, 2025, and the award date is July 15, 2025. This contract is not designated as a set-aside, indicating open competition....
- This federal contract award, valued at $1,583.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company has been...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of COPAXONE 40 MG/ML SYRINGEML. The firm-fixed-price delivery order contract has a ceiling value of $2,122.56 and a completion date of June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML SYRINGEML. The contract has a ceiling value of $3,182.82 and a period of performance ending on May 7, 2025. It is a firm fixed-price contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of COPAXONE 40 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order has a potential value of $2,269.52 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not designated as a...
- This federal contract award is for the delivery of COPAXONE 40 MG/ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $1,849.20, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to...
- This federal contract award, valued at $4,306.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of July 23, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,289.18 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH62PDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,583.28, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Generated 7/24/24, 9:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/24/24 |